{"id":"tp-54314","type":"article-newspaper","title":"Exagen Maintains 2026 Revenue Outlook at $72 Million to $75 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54314","datePublished":"2026-11-11T18:30:28.000Z","dateModified":"2026-11-11T18:30:28.000Z","language":"en","abstract":"Its myositis offering remains on track for an early 2027 launch.","section":"Business","references":[]}